115 related articles for article (PubMed ID: 9820127)
1. Dual effects of nimesulide, a COX-2 inhibitor, in human platelets.
Saeed SA; Afzal MN; Shah BH
Life Sci; 1998; 63(20):1835-41. PubMed ID: 9820127
[TBL] [Abstract][Full Text] [Related]
2. Calcium-dependent synergistic interaction of platelet activating factor and epinephrine in human platelet aggregation.
Saeed SA; Rasheed H
Acta Pharmacol Sin; 2003 Jan; 24(1):31-6. PubMed ID: 12511226
[TBL] [Abstract][Full Text] [Related]
3. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets.
Johnson GJ; Leis LA; Francis GS
Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784
[TBL] [Abstract][Full Text] [Related]
4. Second messengers in platelet aggregation evoked by serotonin and A23187, a calcium ionophore.
Connor JD; Rasheed H; Gilani AH; Cheema M; Rizvi Z; Saeed SA
Life Sci; 2001 Oct; 69(23):2759-64. PubMed ID: 11720080
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase C inhibitor, chelerythrine, potentiates the adrenaline-mediated aggregation of human platelets through calcium influx.
Shah BH; Shamim G; Khan S; Saeed SA
Biochem Mol Biol Int; 1996 May; 38(6):1135-41. PubMed ID: 8739035
[TBL] [Abstract][Full Text] [Related]
6. Activation of rabbit platelets by Ca2+ influx and thromboxane A2 release in an external Ca(2+)-dependent manner by zooxanthellatoxin-A, a novel polyol.
Rho MC; Nakahata N; Nakamura H; Murai A; Ohizumi Y
Br J Pharmacol; 1995 Jun; 115(3):433-40. PubMed ID: 7582454
[TBL] [Abstract][Full Text] [Related]
7. Adenosine potentiates the inhibitory effects of calcium channel antagonists on human platelet aggregation induced by thromboxane A2 or U46619.
Johnson GJ; Leis LA; Francis GS
Thromb Res; 1990 Jul; 59(1):139-48. PubMed ID: 2399526
[TBL] [Abstract][Full Text] [Related]
8. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms involved in human platelet aggregation by synergistic interaction of platelet-activating factor and 5-hydroxytryptamine.
Shah BH; Rasheed H; Rahman IH; Shariff AH; Khan FL; Rahman HB; Hanif S; Saeed SA
Exp Mol Med; 2001 Dec; 33(4):226-33. PubMed ID: 11795484
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction of adrenaline and histamine in human platelet aggregation is mediated through activation of phospholipase, map kinase and cyclo-oxygenase pathways.
Shah BH; Lashari I; Rana S; Saeed O; Rasheed H; Arshad Saeed S
Pharmacol Res; 2000 Nov; 42(5):479-83. PubMed ID: 11023712
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interaction of epinephrine and calcium ionophore in platelet aggregation.
Butt IF; Saeed SA; Waqar SN; Aslam M
J Ayub Med Coll Abbottabad; 2005; 17(2):1-5. PubMed ID: 16092638
[TBL] [Abstract][Full Text] [Related]
12. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine.
Alarayyed NA; Cooper MB; Prichard BN; Betteridge DJ; Smith CC
Br J Clin Pharmacol; 1997 Apr; 43(4):415-20. PubMed ID: 9146854
[TBL] [Abstract][Full Text] [Related]
13. Antithrombogenic effects of calcium channel blockers: synergism with prostacyclin and thromboxane synthase inhibitors.
Onoda JM; Sloane BF; Honn KV
Thromb Res; 1984 Jun; 34(5):367-78. PubMed ID: 6377570
[TBL] [Abstract][Full Text] [Related]
14. Synergism interaction between arachidonic acid by 5-hydroxytryptamine in human platelet aggregation is mediated through multiple signalling pathways.
Saeed SA; Rasheed H; Gilani AU
Acta Pharmacol Sin; 2003 Oct; 24(10):958-64. PubMed ID: 14531936
[TBL] [Abstract][Full Text] [Related]
15. Co-activation of Gi and Gq proteins exerts synergistic effect on human platelet aggregation through activation of phospholipase C and Ca2+ signalling pathways.
Shah BH; Siddiqui A; Qureshi KA; Khan M; Rafi S; Ujan VA; Yakoob MY; Rasheed H; Saeed SA
Exp Mol Med; 1999 Mar; 31(1):42-6. PubMed ID: 10231022
[TBL] [Abstract][Full Text] [Related]
16. Effects of calcium channel blockers on platelet aggregation and thromboxane A2 formation: an in vivo double blind randomized study.
Rostagno C; Prisco D; Paniccia R; Costanzo G; Poggesi L; Boddi M; Abbate R
Thromb Res; 1990 Aug; 59(3):531-9. PubMed ID: 2237825
[TBL] [Abstract][Full Text] [Related]
17. Signaling mechanisms mediated by G-protein coupled receptors in human platelets.
Saeed SA; Rasheed H; Fecto FA; Achakzai MI; Ali R; Connor JD; Gilani AU
Acta Pharmacol Sin; 2004 Jul; 25(7):887-92. PubMed ID: 15210061
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic activity of the non-prostanoid thromboxane A2 receptor antagonist, daltroban (BM 13,505), in human platelets in vitro and in the rat vasculature in vivo.
Bertolino F; Valentin JP; Maffre M; Grelac F; Bessac AM; Maclouf J; Delhon A; Lévy-Toledano S; Patoiseau JF; Colpaert FC
Br J Pharmacol; 1995 May; 115(1):210-6. PubMed ID: 7647979
[TBL] [Abstract][Full Text] [Related]
19. Endothelial cells play an important role in the antiaggregatory effect of nitric oxide.
Klinge JM; Topf HG; Trusen B; Rauh M; Rascher W; Dötsch J
Crit Care Med; 2003 Jul; 31(7):2010-4. PubMed ID: 12847397
[TBL] [Abstract][Full Text] [Related]
20. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
